Biopharmaceuticals
Generics
FDA
Litigation
News Release - May 15, 2014
Mylan Applauds Court's Ruling Dismissing Teva's Suit Against FDA on Copaxone(R)
Source: Mylan
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.